Essential Drugs List for Uganda (EDLU) 2001

Publication date: 2001

Essential Drugs List for Uganda (EDLU) 2001 The National Drug Authority © 2001 by The National Drug Authority All parts of this publication may be reproduced in any form, provided due acknowledgement is given Copies may be obtained from: The Executive Secretary/Registrar National Drug Authority PO Box 23096, Kampala Uganda Tel: 255665 / 255628 / 347391/2 Fax: 255758 Email: nda@imul.com Computer typeset in Arial Truetype Printed and bound in Uganda by Marianum Press, PO Box 11, Kisubi M.V.2001. 2M. JC101/2001 ISBN 9970-719-00-9 Foreword It is my pleasure to present this revised and updated Essential Drugs list for Uganda (EDLU) 2001 to all prescribing and dispensing staff, and to other health professionals handling medicines in Uganda. This 3rd edition of EDLU has been produced in order to take account of the various changes which have taken place in therapeutic practice over the 5 year period since the last edition. Essential drugs are those which satisfy the needs of the majority of the population and should therefore always be available in adequate amounts and appropriate dose forms. EDLU lists those essential drugs considered to be the most appropriate for use in the Uganda public health system. It is also strongly recommended as a rational basis for private sector prescribing. In order to ensure that the correct decision is taken on whether to include a particular item or not, consideration must be made of a number of key criteria including: Efficacy: the capacity of the medicine effectively to treat the diagnosed condition Safety: the therapeutic index of the drug (ratio of treatment dose to toxic dose) and Page 1 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. the nature, frequency and severity of expected side-effects Quality: compliance of the drug presentation with internationally accepted standards of purity, composition, and consistency Cost-effectiveness: considered in terms of available and effective alternative medicines or dose-forms Appropriateness: the overall suitability of the medicine within the local context taking account of various factors including: • Changing morbidity patterns • Stability in storage • Likely compliance with dose regime • Development of resistance • Type of dose form/method of administration • Socio-economic factors In preparing the new EDLU, these criteria have been carefully considered by the Committee on Essential Drugs (CED), assisted as required by experts in the various medical specialities. Drug lists by their very nature are subject to rapid obsolescence due to ever-changing therapeutic requirements for the treatment of conditions found in Uganda. A good example of this is the treatment of malaria which has had to be revised recently to take account of rapidly developing resistance to previous first-line medication. Thus the list should be subject to constant scrutiny and updated accordingly. This process is highly dependent on the input of clinicians in the field who should therefore continuously assess the appropriateness of the selected medicines for treating the conditions encountered. Clinicians are encouraged to submit proposals for amendments to EDLU following the procedures given in the Preface. The EDLU is a guide for drug selection and level of distribution and is meant to be used together with the National Standard Clinical Guidelines (NSCG) which give practical guidance on diagnosis and appropriate therapeutic approaches. Both publications are also useful resource materials for training in all aspects of rational drug use. I wish to thank the Chairman and members of the National Drug Authority Committee on Essential Drugs for the time and effort they have put into the production of this excellent and vital document. It is my sincere hope that routine use of the EDLU in combination with the NSCG by all levels of prescriber in their daily work will greatly assist in ensuring that patients receive optimum treatment of their health problems at all times. However this will only be possible if adequate quantities of the recommended drugs are constantly available for utilisation at the appropriate level of health unit. The Ministry of Health is therefore committed to improving accessibility to required essential drugs through active implementation of the new National Drug Policy which aims inter alia at securing adequate funding of essential drugs procurement and improved management of the drug supply system at all levels. Page 2 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. Dr C W C B Kiyonga MP Hon. Minister of Health Preface and Acknowledgements 1. Background to EDLU 2001 The first and second editions of EDLU were produced in 1991 and 1996 respectively. As with these previous editions which it now supersedes, this new EDLU 2001 is produced with the aim of assisting in making accessible and affordable to the majority of the population those drugs which are necessary for the prevention and treatment of common health problems in the country. The EDLU lists those essential drugs considered to be most suitable for current use in Uganda. The current WHO model list (11th revision December 1999) was used as a basis for EDLU and modified to suit the requirements of Uganda according to the criteria given in the Foreword by the Honourable Minister of Health, and taking into account available resources and currently applicable clinical practice. According to the National Drug Policy the EDLU is a ‘primary drug management tool at all levels of the health system’ and is intended to ‘to strengthen and harmonise the essential drugs selection process at national and district levels for both public and private sectors’. The EDLU should be used ‘as a basis for procurement, prescribing and dispensing in the public health system and its use promoted in the private (profit and non-profit) sector’. Thus it is important to stress that, although the list is designed primarily for public sector use, it is equally appropriate for private sector prescribers who are strongly encouraged to select EDLU drugs whenever possible. Numerous changes have been made to EDLU to bring it into line with currently accepted therapeutic requirements. These are summarised on pages xix-xxvi. 2. Amendment of EDLU 2001 As stated in the Foreword, the EDLU will be subject to constant review and revision. All clinicians should therefore fully familiarise themselves with the contents of the EDLU and continuously evaluate its relevance and appropriateness to their daily work. Proposals for amendments to EDLU, together with supporting arguments and any available relevant literature, should be forwarded in writing to: The Chairman National Drug Authority Committee on Essential Drugs PO Box 23096, Kampala Tel: 255665 / 255628 / 347391 / 347392 Fax: 255758 Email nda@imul.com According to the National Drug Policy, the EDLU is supposed to be revised at least every three years, thus the next edition should be produced by 2004. In the meantime, any proposals will be discussed by the Committee on Essential Drugs. Agreed amendments to the list will be notified to all prescribers through Ministry of Health circulars as appropriate. 3. Acknowledgements Page 3 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. Preparation of this vital publication would not have been possible without the dedication and hard work of my fellow contributing members of the Committee on Essential Drugs who are listed on pages xv-xvi and without the invaluable contributions of the key clinical specialists listed on page xvii. I wish to express my sincere thanks to them all for their time and efforts. I am also greatly indebted to the Chairman and Executive Secretary / Registrar of NDA for facilitating the completion of this work through the provision of a most suitable and supportive working environment and to the NDA Secretariat staff for their continuous technical and administrative support. Dr A Lukanga-Ndawula MB ChB, FRCS(Ed) Chairman, NDA Committee on Essential Drugs Contributing Members of the NDA Committee on Essential Drugs (CED) 1. Dr A Lukanga-Ndawula Chief of Medical Services, Uganda Peoples Defence Forces (UPDF) Chairman, Committee on Essential Drugs 2. Dr E Owino Head, Dept. of Pharmacy, Makerere University 3. Dr G W Zirembuzi Senior Consultant Paediatrician, Mulago Hospital, Kampala 4. Dr J G M Jagwe (ex officio) Chairman, NDA 5. Prof G R Nzarubara Surgeon, Dept. of Surgery, Mulago Hospital, Kampala 6. Dr C W Kadama Private Medical Practitioner, Centenary Clinic, Kampala representing the Private Medical Practitioners Association 7. Ms D A Kusemererwa Senior Pharmacist, Joint Medical Store (JMS), Kampala 8. Dr E K Kanyesigye Assistant Commissioner of Health Services (Clinical) Ministry of Health, Kampala Page 4 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 9. Mr G K Sematiko Senior Pharmacist, Mulago Hospital, Kampala 10. Dr B A Mpeka-Tusubira Assistant Commissioner Clinical Services Ministry of Health, Kampala 11. Dr S Ndyanabangi Principal Medical Officer, Ministry of Health, Kampala 12. Mrs C Ntegyeka Pharmacist, Dept. of Pharmacy, Makerere University 13. Dr J C Lule Acting Executive Secretary / Registrar National Drug Authority Secretary, Committee on Essential Drugs 14. Mr C J Forshaw Pharmaceutical Advisor, National Drug Authority DANIDA/Uganda Health Sector Support Programme Editor, EDLU Contributing Clinical Specialists 1. Dr M Mungherera Psychiatrist, Butabika Hospital, Kampala 2. Prof T Clshoz Professor of Anaesthesiology, University Hospital, Mbarara 3. Associate Prof M Kawuma Dept. of Ophthalmology, Makerere Medical School, Mulago Hospital, Kampala 4. Dr J V B Tindimwebwa Head, Dept. of Anaesthesia, Makerere Medical School, Mulago Hospital, Kampala 5. Mr E K Naddumba Page 5 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. Head, Dept. of Orthopaedics, Makerere Medical School, Mulago Hospital, Kampala Presentation of Information 1. General Drug names: the relevant International Non-proprietary Name (INN) or generic name are used throughout the list. According to the National Drug Policy and Authority Statute 1993 sec 12 generic names shall be used for prescribing and labelling (ie. including dispensing) of drugs, except where no such generic or suitable alternative non-proprietary name exists. Order of sections: drugs are arranged in alphabetical order by pharmacological / therapeutic groups following the same basic arrangement as the WHO Model List of Essential Drugs with the addition of two additional sections: 28: Ear, Nose and Oropharyngeal Preparations and 29: Drugs for Neurosurgical Use. 2. Level of Use For each item the lowest level of health care facility at which the item may be used is indicated as shown in the table below. This designation is in line with the diagnostic and clinical skills expected to be available at that level. In certain cases the use of an item is further restricted to facilities where a specific type of clinical and/or diagnostic expertise is available, eg. certain ophthalmological preparations. The in-charge of each level of Health Centre is given in parentheses. Notes: 1. Diagnostic facilities: Health facilities of levels HC3 and higher have different degrees of laboratory diagnostic support facilities available. 2. Drug availability: all of the items listed for health centre levels up to and including H (Hospital) level are expected to be available at all times from National Medical Stores. More specialised items with an R (Restricted) or Ref (Referral) designation will be available from NMS only at the request of the relevant institution. It is therefore important that accurate estimates for the annual requirements for these items are made by the institutions concerned well in advance and the information forwarded to NMS so that sufficient quantities of the required items may be procured and held in stock. Abbreviations and Units HC1 = Health Centre 1 (Community Level) HC2 = Health Centre 2 (Enrolled Comprehensive Nurse) HC3 = Health Centre 3 (Clinical Officer) HC4 = Health Centre 4 (Medical Officer) H = Hospital R = Restricted Use (ie. needs high level diagnostic/clinical skills only available in specialised institutions, eg. Cancer Institute, National Psychiatric Hospital, etc.) Ref = Referral Hospital BNF = British National Formulary BP = British Pharmacopoeia Page 6 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. Summary of Main Changes in EDLU 2001 A. Additions BPC = British Pharmaceutical Codex Inf = infusion IM = intramuscular Inj = injection IT = intrathecal IU = international units IV = intravenous MU = Mega Unit = one million (1,000,000) units PFR = powder for reconstitution SC = subcutaneous SR = slow-release G = gram = 1,000 mg = 0.001 kg mg = milligram = 1,000 µg µg = microgram = 0.001mg L = litre = 1,000 mL mL = millilitre = 0.001 L 1.1 General anaesthetics and oxygen propofol injection 10mg/mL IV R 1.2 Local anaesthetics lignocaine spray 10% HC4 1.3 Preoperative and peri-operative medication ephedrine hydrochloride injection 3mg/mL Ref fentanyl injection 50µg/mL Ref midazolam injection 2mg/mL Ref 2.3 Opioid analgesics morphine oral solution 1mg/mL HC3 4.1 Antidotes (General) charcoal activated tablet 250mg HC2 4.2 Antidotes (Specific) sodium thiosulphate injection 250mg or 500mg/mL H 6.1.1 Intestinal anthelminthics mebendazole tablet 500mg HC1 6.2.1 Penicillins flucloxacillin oral susp (PFR) 125mg/5mL HC4 6.2.2 Other antibacterial drugs ceftriaxone powder for inj 250mg IV/IM Ref ciprofloxacin tablet 500mg HC3 6.2.4 Antituberculosis drugs Page 7 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. ethambutol + isoniazid tablet 400mg + 150mg HC4 6.3 Antifungal drugs clotrimazole pessary 500mg HC4 6.4.1 Antiamoebic drugs tinidazole tablet 500mg HC4 6.4.3 Antimalarial drugs artemether injection 100mg IM HC4 artemether tablet 50mg HC4 sodium artesunate tablet 50mg HC4 6.4.4 Antitrypanosomal drugs (African trypanosomiasis) nifurtimox tablet 30mg R nifurtimox tablet 120mg R nifurtimox tablet 250mg R 6.4.6 Drugs used in toxoplasmosis clindamycin capsule 150mg HC4 pyrimethamine tablet 25mg HC4 10.1 Antianaemia drugs ferrous sulphate + folic acid tab 60mg elem.iron + 400µg HC1 12.1 Antianginal drugs atenolol tablet 100mg H 12.2 Antidysrhythmic drugs atenolol tablet 100mg H 12.3 Antihypertensive drugs nifedipine tablet 10mg H nifedipine tablet 20mg SR H 12.4.2 Drugs used in vascular shock hydrocortisone sod. succinate injection (PFR) 100mg IV/IM HC3 13.1 Topical antifungals miconazole cream 2% H 13.2 Topical antiinfectives potassium permanganate solution aq 1:10,000 (0.01%) HC4 silver sulphadiazine cream 1% HC3 13.3 Topical antiinflammatories and antipruritics betamethasone cream or ointment 0.1% HC4 13.4 Keratoplastics and keratolytics benzoyl peroxide lotion or cream 5% HC4 13.6 Pediculicide malathion lotion aqueous 0.5% HC2 14.1 Ophthalmic diagnostic agents rose bengal eye drops 1% HC4 17.1 Antacids and other antiulcer drugs omeprazole tablet 20mg H 17.2 Antiemetics cyclizine tablet 50mg Ref Page 8 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. cyclizine inj 50mg/mL IM/slow IV Ref domperidone tablet 10mg H domperidone suspension 5mg/5mL H domperidone suppository 30mg H 17.4 Antispasmodics propantheline tablet 15mg H 17.6 Laxatives senna tablet 7.5mg HC2 17.7.2 Antidiarrhoeals loperamide tablet or capsule 2mg H 18.1 Adrenal hormones & synthetic substitutes dexamethasone tablet 4mg H 18.5 Insulins and other antidiabetic agents isophane insulin injection 100 IU/mL SC HC4 19.1 Diagnostic agents tuberculin PPD injection 100 IU/mL HC3 19.2 Sera and immunoglobulins antirabies immunoglobulin, injection 200 IU/mL HC4 human IM/local infiltration 20. Muscle relaxants & cholinesterase inhibitors atracurium besylate injection 10mg/mL Ref 21.1.1 Antiinfective + antiinflammatory agents neomycin + betamethasone eye drops 0.5% + 0.1% HC4 22.1 Oxytocics ergometrine + oxytocin injection 500µg + 5 IU/mL IM HC2 22.2 Antioxytocics salbutamol injection 1mg/mL IV inf HC4 25.1 Antiasthmatic drugs aminophylline tablet 100 mg HC3 cromoglycic acid inhaler 5mg/metered dose (for adults) HC4 salbutamol nebuliser solution 2.5mg/mL H salbutamol nebuliser solution 5mg/mL H 25.2 Antitussive drug codeine phosphate tablet 30mg HC4 27. Vitamins and minerals ergocalciferol tablet or capsule 250µg Ref pyridoxine tablet 50mg HC4 retinol (vitamin A) capsule (drops) 50,000 IU HC2 retinol (vitamin A) capsule (drops) 100,000 IU HC2 28.1 Ear preparations betamethasone ear/eye drops 0.1% H 28.3 Oropharygeal preparations povidone-iodine mouthwash/gargle 1% HC3 triamcinolone acetonide oral paste 0.1% H Page 9 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. B. Deletions 1.2 Local anaesthetics lignocaine spray 5% Hosp 2.1 Non-opioids acetylsalicylic acid tablet 75mg HC 3. Anti-allergics & drugs used in anaphylaxis astemizole tablet 10mg Ref 4.1 Antidotes (General) charcoal activated tablet 50mg HC 4.2 Antidotes (Specific) ferric hexacyanoferrate powder Hosp sodium thiosulphate injection 1.5G/50mL Hosp 5. Antiepileptics and anticonvulsants phenobarbitone (phenobarbital) tablet 30mg HC phenobarbitone tablet 60mg HC 6.1.1 Intestinal anthelminthics mebendazole tablet 100mg HC 6.1.3 Antischistosomals niridazole tablet 600mg Ref 6.2.1 Penicillins ampicillin powder for syrup 125mg/5mL Hosp ampicillin tablet or capsule 250mg Hosp cloxacillin powder for syrup 125mg/5mL Hosp 6.2.2 Other antibacterial drugs cephalexin tablet 250mg R lincomycin capsule 500mg Ref tetracycline tablet / capsule 250mg HC 6.2.4 Antituberculosis drugs rifampicin tablet / capsule 150mg Ref 6.4.3 Antimalarial drugs chloroquine injection 200mg base/5mL HC primaquine tablet 15mg HC pyrimethamine tablet 25mg Hosp 8.3 Hormones and antihormones stilboestrol tablet 5mg R 12.1 Antiangina drugs cinnarizine tablet 75mg Ref propranolol tablet 40mg Hosp 12.3 Antihypertensive drugs diazoxide injection 300mg/20mL Hosp 13.1 Topical antifungals griseofulvin tablet 250mg, 500mg Hosp 13.4 Astringent drugs aluminium diacetate solution 13% Hosp Page 10 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 14.1 Ophthalmic diagnostic agents homatropine eye drops 1% Hosp 17.2 Antiemetics chlorpromazine tablet 25mg HC chlorpromazine injection 25mg/mL deep IM Hosp chlorpromazine suppository 100mg Hosp prochlorperazine suppository 5mg HC prochlorperazine suppository 25mg HC 17.4 Anti-inflammatory drug sulfasalazine tablet 500mg R 17.5 Antispasmodic drugs atropine injection 1mg/mL Hosp hyoscine butylbromide tablet 10mg Hosp 18.1 Adrenal hormones and synthetic substitutes vasopressin spray 10µg/dose Ref vasopressin injection 5 IU Ref 18.7 Progestogens medroxyprogesterone acetate injection 50mg/mL HC 19.1 Diagnostic agents tuberculin, PPD with Tween 80 injection 5 IU/0.1mL HC tuberculin, PPD with Tween 80 injection 5 IU/mL HC 19.2 Sera and immunoglobulins antirabies immunoglobulin, injection 1,000 IU Hosp human IM/local infiltration 19.3.2 Vaccines for specific groups of individuals cholera vaccine inj 10mL/vial, 1.5mL/vial Hosp 21.1.1 Antiinfective + antiinflammatory agents neomycin + beclomethasone eye drops 0.5% + 0.1% R 25.1 Antiasthmatic drugs aminophylline tablet 200 mg HC cromoglycic acid inhaler 1mg/dose Ref 25.2 Antitussive drug codeine phosphate tablet 10mg Hosp 26.2 Parenterals glucose infusion 10% HC 26.3 Miscellaneous water for injection injection 100mL HC 27. Vitamins and minerals calciferol injection 10,000 IU Hosp pyridoxine tablet 25mg Hosp vitamin B+C (Parenterovite) injection 5mL Ref yeast dried tablet 300mg HC 28.1 Ear preparations boric acid in spirit ear drops 1:16 (6.25%) H Page 11 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. ESSENTIAL DRUGS LIST FOR UGANDA 1. ANAESTHETICS 1.1 General anaesthetics and oxygen1 1 Soda lime must be available for CO2 absorption during closed circuit general anaesthesia 1.2 Local anaesthetics chloramphenicol ear drops 0.5% H hydrogen peroxide solution 3% H ichthammol in glycerol ear drops 10% H oxytetracycline + polymyxin B ear drops 0.5% + 0.119% H salicylic acid ear drops 2% H salicylic acid ear drops 10% H 28.2 Nasal preparations cromoglycic acid nasal spray 2% Hosp ephedrine nasal drops 0.5% HC 28.3 Oropharygeal preparations alkaline phenol mouth wash solution HC alkaline phenol gargle solution 1% HC 28.4 Miscellaneous chromic acid solution 25% Ref silver nitrate solution 0.5%-4% Hosp ether inhalation HC4 halothane inhalation HC4 ketamine injection 50mg/mL IV/IM HC4 ketamine injection paed 10mg/mL IV/IM HC4 nitrous oxide medical gas HC4 oxygen medical gas HC4 propofol injection 10mg/mL IV Ref thiopental injection (PFR) 500mg IV HC4 bupivacaine injection 0.25% IT/SC Ref bupivacaine injection 0.5% IT/SC Ref ethyl chloride spray HC3 lignocaine injection 2% (epidural) H lignocaine dental cartridge 2% HC4 lignocaine injection 2% HC2 lignocaine spray 10% HC4 lignocaine paste 2-4% HC4 Page 12 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 1.3 Preoperative and peri-operative medication 2. ANALGESICS, ANTIPYRETICS 2.1 Non-opioids 2.2 Drugs used for gout 2.3 Opioid analgesics lignocaine ointment 5% HC4 lignocaine injection 5% (heavy spinal) H lignocaine gel 2% HC3 lignocaine + epinephrine dental cartridge 2%+1:80 000 HC4 atropine injection 1mg/mL IV/IM HC4 diazepam rectal tube 2mg/mL HC2 droperidol injection 5mg/mL IV/IM/IVinf H ephedrine hydrochloride injection 3mg/mL Ref fentanyl injection 50µg/mL Ref lorazepam injection 4mg/mL IV/IM H midazolam injection 2mg/mL Ref morphine injection 15mg/mL IV/IM/SC HC4 acetylsalicylic acid tablet 300mg HC1 diclofenac tablet 25mg HC4 diclofenac injection 25mg/mL IV/IM H ibuprofen tablet 200mg HC2 paracetamol tablet 500mg HC1 paracetamol suppository 100mg HC3 allopurinol tablet 100mg HC4 colchicine tablet 500µg HC4 indomethacin tablet 25mg HC4 probenecid tablet 500mg HC4 codeine tablet 30mg HC4 dihydrocodeine tablet 30mg HC4 morphine injection 15mg/mL IV/IM/SC HC4 morphine oral solution 1mg/mL HC3 morphine tablet 30mg HC4 morphine tablet SR 10mg HC3 morphine tablet SR 30mg HC3 morphine tablet SR 60mg HC3 papaveretum + hyoscine injection 15.4mg + 0.4mg Ref pethidine tablet 50mg HC4 Page 13 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 3. ANTI-ALLERGICS & DRUGS USED IN ANAPHYLAXIS 4. ANTIDOTES 4.1 General 4.2 Specific 5. ANTIEPILEPTICS AND ANTICONVULSANTS pethidine injection 50mg/mL IV/IM/SC HC3 chlorphenamine tablet 4mg HC2 cyproheptadine tablet 4mg H cyproheptadine syrup 2mg/5mL H dexamethasone injection 4mg/mL IV/IM HC4 epinephrine (adrenaline) injection 1mg/mL IV/IM/SC HC2 hydrocortisone sod. succinate injection (PFR) 100mg IV/IM HC3 prednisolone tablet 5mg HC4 promethazine tablet 25mg HC2 promethazine injection 25mg/mL slow IV/IM HC4 charcoal activated tablet 250mg HC2 ipecacuanha syrup 0.14% HC2 pralidoxime injection 200mg/mL IV/IM HC4 atropine injection 1mg/mL IV/IM HC4 benztropine injection 1mg/mL IV/IM HC4 calcium folinate (folinic acid) tablet 15mg Ref calcium folinate (folinic acid) injection 3mg/mL IV/IM Ref deferoxamine injection (PFR) 500mg IV H dimercaprol injection 50mg/mL IM H methionine tablet 250mg H methylthioninium chloride (methylene blue) injection 10mg/mL IV H naloxone injection 400µg/mL IV/IM/SC HC4 naloxone inj paed 20µg/mL IV/IM/SC HC4 penicillamine tablet 250mg H sodium calcium edetate injection 200mg/mL IV H sodium nitrite injection 30mg/mL IV H sodium thiosulphate inj 250mg/mL or 500mg/mL IV H carbamazepine tablet 200mg HC4 carbamazepine syrup 100mg/5mL HC4 clonazepam tablet 2mg Ref clonazepam injection 500mg/mL IV Ref diazepam injection 5mg/mL IV HC4 Page 14 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 6. ANTI-INFECTIVE DRUGS 6.1 Anthelmintics 6.1.1 Intestinal anthelminthics 6.1.2 Antifilarials 6.1.3 Antischistosomals 6.2 Antibacterials 6.2.1 Beta Lactam Drugs diazepam rectal tube 2mg/mL HC2 ethosuximide tablet 250mg H ethosuximide syrup 250mg/5mL H magnesium sulphate (specifically for convulsions in eclampsia) injection 500mg/mL (50%) IV HC3 phenobarbitone (phenobarbital) injection 200mg/mL IV/IM Ref phenytoin injection 10mg/mL IV Ref phenytoin tablet or capsule 50mg HC3 phenytoin tablet or capsule 100mg HC3 phenytoin suspension 30mg/5mL HC3 valproic acid tablet 200mg Ref mebendazole tablet 500mg HC1 niclosamide tablet 500mg HC4 diethylcarbamazine tablet 50mg H ivermectin tablet 6mg HC3 praziquantel tablet 600mg HC3 amoxicillin tablet or capsule 250mg HC2 amoxicillin tablet or capsule 500mg HC2 amoxicillin inj (PFR) 500mg IV/IM/IVinf HC4 amoxicillin syrup (PFR) 125mg/5mL HC2 amoxicillin + clavulanic acid tablet 250mg + 125mg Ref ampicillin inj (PFR) 500mg IV/IM/IVinf HC4 benzathine benzylpenicillin injection (PFR) 2.4 MU IM HC3 benzylpenicillin inj (PFR) 1MU (600mg) IM HC2 ceftriaxone injection (PFR) 250mg IV/IM Ref cefuroxime axitel tablet 250mg Ref cefuroxime sodium injection (PFR) 750mg IV/IM Ref cefuroxime oral susp (PFR) 125mg/5mL Ref cloxacillin injection (PFR) 500mg IV/IM HC4 flucloxacillin capsule 250mg HC4 Page 15 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 6.2.2 Other antibacterial drugs 6.2.3 Antileprosy drugs1 1 may be available at designated health centres 6.2.4 Antituberculosis drugs 2 rifampicin products are reserved for TB/Leprosy Programme use only flucloxacillin syrup (PFR) 125mg/5mL HC4 phenoxymethylpenicillin tablet 250mg (Pen V) HC2 procaine benzylpenicillin forte injection (PFR) 4 MU IM (PPF) HC3 chloramphenicol injection (PFR) 1G IV/IM HC3 chloramphenicol capsule 250 mg HC4 ciprofloxacin tablet 250mg HC3 ciprofloxacin tablet 500mg HC3 cotrimoxazole tablet 120mg HC2 cotrimoxazole tablet 480mg HC2 cotrimoxazole syrup 240mg/5mL HC2 doxycycline tablet 100mg HC2 erythromycin oral susp (PFR) 125mg/5mL HC4 erythromycin tablet 250mg HC2 gentamicin injection 40mg/mL IV/IM HC4 metronidazole infusion 5mg/mL H metronidazole tablet 200mg HC2 nalidixic acid tablet or capsule 500mg H nitrofurantoin tablet 100mg HC2 clofazimine capsule 100mg R dapsone tablet 100mg R rifampicin2 tablet or capsule 150mg R thalidomide tablet 50mg R ethambutol tablet 400mg HC4 ethambutol + isoniazid tablet 400mg+150mg HC4 isoniazid tablet 100mg HC4 pyrazinamide tablet 500mg HC4 rifampicin + isoniazid2 tab or cap 150mg+100mg HC4 rifampicin + isoniazid2 tab or cap 300mg+150mg HC4 rifampicin + isoniazid2 syrup 100mg+50mg/5mL HC4 streptomycin injection (PFR) 1G deep IM HC4 Page 16 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 6.3 Antifungal drugs 6.4 Antiprotozoal drugs 6.4.1 Antiamoebic drugs 6.4.2 Antileishmaniasis drugs 6.4.3 Antimalarial drugs 6.4.4 Antitrypanosomal drugs (African trypanosomiasis) amphotericin B inj (PFR) 50mg for IV inf Ref clotrimazole pessary 500mg HC4 fluconazole tablet or capsule 50mg Ref fluconazole tablet or capsule 100mg Ref fluconazole tablet or capsule 200mg Ref flucytosine injection 10mg/mL for IV inf Ref griseofulvin tablet 125mg HC3 griseofulvin tablet 500mg HC3 ketoconazole oral susp 100mg/5mL HC3 ketoconazole tablet 200mg HC3 miconazole pessary 100mg HC4 nystatin pessary 100,000 IU HC3 nystatin oral susp 100,000 IU/mL HC2 nystatin tablet 500,000 IU HC3 metronidazole tablet 200mg HC2 tinidazole tablet 500mg HC4 pentamidine isethionate inj (PFR) 200mg deep IM HC4 sodium stibogluconate inj 100mg/mL antimony IV/IM R amodiaquine tablet 200mg HC3 artemether injection 100mg IM HC4 artemether tablet 50mg HC4 chloroquine inj 40mg base/mL IM/SC HC2 chloroquine tablet 150mg base HC1 chloroquine syrup 75mg base/5mL HC1 primaquine tablet 7.5mg HC4 proguanil tablet 100mg HC4 quinine inj 300mg/mL IV/deep IM HC3 quinine tablet 300mg HC4 quinine mixture 100mg/5mL HC4 sodium artesunate tablet 50mg HC4 sulfadoxine + pyrimethamine tablet 500mg + 25mg (SP) HC1 Page 17 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 6.4.5 Antitrichomoniasis drugs 6.4.6 Drugs used in toxoplasmosis 6.5 Antiviral drugs 7. ANTIMIGRAINE DRUGS 7.1 Treatment of Acute Attacks 7.2 Prophylaxis 8. ANTINEOPLASTIC & IMMUNOSUPPRESSIVE DRUGS 8.1 Immunosuppressive drugs 8.2 Cytotoxic drugs melarsoprol injection 36mg/mL slow IV HC4 nifurtimox tablet 30mg R nifurtimox tablet 120mg R nifurtimox tablet 250mg R pentamidine isethionate inj (PFR) 200mg deep IM HC4 suramin sodium injection (PFR) 1G slow IV HC4 tinidazole tablet 500mg HC4 clindamycin capsule 150mg HC4 pyrimethamine tablet 25mg HC4 aciclovir tablet 200mg HC4 aciclovir tablet 400mg HC4 ganciclovir sodium injection (PFR) 500mG IV inf (for cytomegalovirus infection) R acetylsalicylic acid tablet 300mg HC1 ergotamine tablet 1mg HC4 paracetamol tablet 500mg HC1 propranolol tablet 10mg HC4 propranolol tablet 20mg HC4 azathioprine tablet 50mg R asparaginase (colaspase) injection (PFR) 100mg Ref calcium folinate (folinic acid) tablet 15mg Ref calcium folinate (folinic acid) injection 3mg/mL IV/IM/IVinf Ref cyclophosphamide injection (PFR) 500mg IV Ref Page 18 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 8.3 Hormones and antihormones 9. ANTI-PARKINSONISM DRUGS 10. DRUGS AFFECTING THE BLOOD 10.1 Antianaemia drugs 10.2 Anticoagulants and antagonists cyclophosphamide tablet 50mg Ref cytarabine inj (PFR) 100mg SC/IV/IT Ref dacarbazine injection (PFR) 100mg IV Ref dactinomycin injection (PFR) 500µg IV Ref daunorubicin injection (PFR) 50mg IVinf Ref doxorubicin (adriamycin) injection (PFR) 50mg IVinf Ref fluorouracil injection 500mg/10mL IV R hydroxyurea capsule 500mg R mercaptopurine tablet 50mg R methotrexate tablet 2.5mg R methotrexate injection 50mg/mL IV/IM/IT Ref mustine injection (PFR) 10mg IVinf R procarbazine capsule 50mg R stilboestrol tablet 5mg R thioguanine tablet 40mg R vincristine injection (PFR) 1mg IV R vincristine injection (PFR) 5mg IV R dexamethasone tablet 4mg HC4 dexamethasone inj 4mg/mL IM/slow IV/IVinf HC4 prednisolone tablet 5mg HC4 tamoxifen tablet 10mg HC4 benzhexol tablet 2mg HC4 benztropine injection 1mg/mL IV/IM HC4 levodopa + carbidopa tablet 100mg + 10mg Ref levodopa + carbidopa tablet 250mg + 25mg Ref ferrous salt tablet 60mg elemental iron HC1 ferrous sulphate oral solution paediatric BP HC2 12mg elemental iron/5mL ferrous sulphate + folic acid tab 60mg elem.iron + 400µg HC1 folic acid tablet 1mg HC2 folic acid tablet 5mg HC2 hydroxocobalamin injection 1mg/mL IM HC4 Page 19 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 10.3 Fibrinolytic Agents 11. BLOOD PRODUCTS & PLASMA SUBSTITUTES 11.1 Plasma expanders 11.2 Plasma extracts 12. CARDIOVASCULAR DRUGS 12.1 Antianginal drugs 12.2 Antidysrhythmic drugs 12.3 Antihypertensive drugs heparin injection 5,000 IU IV HC4 phytomenadione injection 1mg/mL IM HC4 phytomenadione injection 10mg/mL IM HC4 protamine sulphate injection 10mg/mL slow IV HC4 warfarin tablet 1mg HC4 warfarin tablet 3mg HC4 streptokinase injection 250,000 IU slow IV R dextran 70 infusion IV 6% HC4 polygeline solution infusion IV 3.5% HC4 factor IX complex concentrate injection freeze-dried IV R factor VIII concentrate injection freeze-dried IV R albumin, human injection freeze-dried 25% IV R atenolol tablet 100mg H glyceryl trinitrate tablet sublingual 500µg H glyceryl trinitrate patch 200µg H isosorbide dinitrate tablet sublingual 5mg H nifedipine tablet 10mg H atenolol tablet 100mg H lignocaine inj 20mg/mL (2%) slow IV/IVinf Ref procainamide tablet 250mg Ref propranolol injection 1mg/mL slow IV Ref propranolol tablet 40mg H quinidine tablet 200mg Ref verapamil tablet 40mg Ref atenolol tablet 100mg H Page 20 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 12.4 Drugs used in heart failure 12.4.1 Cardiac glycosides 12.4.2 Drugs used in vascular shock 13. DERMATOLOGICAL DRUGS 13.1 Topical antifungals 13.2 Topical antiinfectives 13.3 Topical antiinflammatories and antipruritics captopril tablet 25mg H hydralazine tablet 25mg H hydralazine tablet 50mg H hydralazine injection 20mg/mL slow IV/IVinf H methyldopa tablet 250mg HC4 nifedipine tablet 10mg H nifedipine tablet 20mg SR H propranolol tablet 40mg HC4 propranolol tablet 80mg HC4 digoxin tab paed 62.5µg (0.0625mg) HC4 digoxin tablet 250µg (0.25mg) HC4 digoxin injection 250µg/mL IV HC4 dopamine injection 40mg/mL IVinf H epinephrine (adrenaline) injection 1mg/mL IC/IVinf HC4 hydrocortisone sod. succinate injection (PFR) 100mg IV/IM HC3 benzoic acid + salicylic acid ointment 6% + 3% HC2 clotrimazole cream 1% HC3 miconazole cream 2% H nystatin cream or oint 100,000 IU/g HC3 sulphur + salicylic acid cream or oint 2% + 2% Hosp acetic acid solution 10% H chlorhexidine cream 5% HC4 framycetin impregnated gauze 1% HC3 iodine tincture 2% HC1 methylrosanilinium chloride aqueous paint 1% HC1 (gentian violet) neomycin + bacitracin ointment 5mg + 500IU/g H potassium permanganate solution aq 1:10,000 (0.01%) HC4 silver sulphadiazine cream 1% HC3 Page 21 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 13.4 Keratoplastics and keratolytics 13.5 Scabicide 13.6 Pediculicide 13.7 Other topical preparations 14. DIAGNOSTIC AGENTS 14.1 Ophthalmic diagnostic agents1 1 for use only where ophthalmological expertise is available 14.2 Radiocontrast media betamethasone cream or ointment 0.1% HC4 calamine lotion 15% HC1 hydrocortisone cream or ointment 1% HC3 benzoyl peroxide lotion or cream 5% HC4 coal tar ointment 1% H dithranol ointment 0.1% H podophyllum resin paint 15% HC4 salicylic acid ointment 2% HC2 salicylic acid ointment 5% HC2 benzyl benzoate lotion 25% HC2 malathion lotion aqueous 0.5% HC2 silver nitrate stick 40% HC3 fluorescein eye drops 1% HC4 physostigmine eye drops 0.25% HC4 rose bengal eye drops 1% HC4 barium sulphate powder in water 75% w/v or more H diatrizoate injection 60% H diatrizoate injection 76% H iodised oil fluid injection 38% H ioglycamate injection 17% H ioglycamate injection 35% H iohexol injection 18% H iohexol injection 24% H iohexol injection 30% H Page 22 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 15. DISINFECTANTS and ANTISEPTICS 15.1 Antiseptics 15.2 Disinfectants 16. DIURETICS 17. GASTROINTESTINAL DRUGS 17.1 Antacids and other antiulcer drugs 17.2 Antiemetics iohexol injection 35% H iopanoic acid tablet 500mg H iothalamate injection 54% H iothalamate injection 60% H iothalamate injection 70% H cetrimide + chlorhexidine solution 0.5% + 0.05% HC2 chlorhexidine gluconate solution 20% HC2 hydrogen peroxide solution 6% HC2 povidone iodine solution 10% HC3 calcium or sodium hypochlorite solution 5% HC1 glutaraldehyde solution 2% H bendrofluazide tablet 5mg HC3 furosemide inj 10mg/mL IM/slow IV/IVinf HC4 furosemide tablet 40mg HC4 mannitol injectable sol. 20% IVinf H spironolactone tablet 50mg HC4 bismuth chelate tablet 120mg Ref cimetidine tablet 400mg HC4 magnesium trisilicate co. Tablet 370mg HC1 omeprazole tablet 20mg H ranitidine tablet 150mg H cyclizine tablet 50mg Ref cyclizine inj 50mg/mL IM/slow IV Ref domperidone tablet 10mg H domperidone suspension 5mg/5mL H domperidone suppository 30mg H prochlorperazine tablet 5mg HC3 Page 23 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 17.3 Antihaemorrhoidals 17.4 Antispasmodics 17.5 Laxatives 17.6 Drugs used in diarrhoea 17.6.1 For oral rehydration 17.6.2 Antidiarrhoeals1 1 for symptomatic treatment of adults only 18. HORMONES, OTHER ENDOCRINE DRUGS & CONTRACEPTIVES 18.1 Adrenal hormones & synthetic substitutes prochlorperazine injection 12.5mg/mL deep IM HC4 promethazine tablet 25mg HC2 promethazine injection 25mg/mL deep IM HC3 metoclopramide tablet 10mg HC3 metoclopramide injection 5mg/mL HC4 bismuth subgallate compound suppository HC3 hyoscine butylbromide injection 20mg/mL Ref propantheline tablet 15mg H bisacodyl tablet 5mg HC4 bisacodyl suppository paediatric 5mg HC4 senna tablet 7.5mg HC2 oral rehydration salts powder for 1L (WHO citrate formula) HC1 codeine phosphate tablet 30mg HC4 loperamide tablet or capsule 2mg H ACTH (corticotrophin) injection 20IU/mL IM Ref betamethasone tablet 0.5mg Ref cortisone tablet 12.5mg Ref cortisone tablet 25mg Ref dexamethasone tablet 4mg H dexamethasone inj 4mg/mL IM/slow IV/Ivinf H hydrocortisone sod succinate inj 100mg IM/slow IV/Ivinf HC3 prednisolone tablet 5mg HC4 Page 24 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 18.2 Androgens 18.3 Hormonal contraceptives 18.4 Oestrogens 18.5 Insulins and other antidiabetic agents 1 The 40IU/mL strength is to be phased out 18.6 Ovulation inducers 18.7 Progestogens 18.8 Thyroid hormones and antithyroid drugs methyltestosterone tablet 5mg Ref testosterone enanthate inj oily 250mg/mL slow IM Ref ethinylestradiol + levonorgestrel tablet 30µg +150µg HC2 ethinylestradiol + levonorgestrel tablet 30µg +300µg HC2 ethinylestradiol + levonorgestrel tablet 50µg +250µg HC2 ethinylestradiol + norethisterone tablet 50µg + 1mg HC2 medroxyprogesterone acetate depot inj 150mg/mL deep IM HC3 levonorgestrel implant capsules 38mg/cap H norgestrel tablet 75µg HC2 stilboestrol tablet 1mg Ref stilboestrol tablet 5mg Ref glibenclamide tablet 5 mg HC4 insulin soluble inj 40 IU/mL or 100 IU/mL SC1 HC4 insulin zinc suspension (lente) inj 40 IU/mL or 100 IU/mL SC1 HC4 isophane insulin injection 100 IU/mL SC HC4 metformin tablet 500mg Ref metformin tablet 850mg Ref tolbutamide tablet 500 mg HC4 bromocriptine tablet 2.5mg Ref clomifene tablet 50mg Ref norethisterone tablet 5 mg H carbimazole tablet 5mg H levothyroxine tablet 100µg HC4 iodine + potassium iodide oral solution 5% + 10% (Lugol’s iodine) HC4 Page 25 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 19. IMMUNOLOGICALS<sup>2</sup> 2 See individual product literature for more information 19.1 Immunological diagnostic agents 19.2 Sera and immunoglobulins 19.3 Vaccines 19.3.1 Vaccines for routine immunisation 19.3.2 Vaccines for specific groups of individuals 20. MUSCLE RELAXANTS & CHOLINESTERASE INHIBITORS tuberculin PPD injection 100 IU/mL HC3 anti-D immunoglobulin human injection 250µg/mL IM Ref antirabies immunoglobulin, injection 200 IU/mL HC4 human IM/local infiltration antirabies vaccine, human diploid injection IM/deep SC HC4 antiscorpion serum injection Ref antitetanus immunoglobulin, human injection 500 IU IM Ref antivenom sera polyvalent (East & Central Africa) injection IV HC4 diphtheria antitoxin injection 10,000 IU IM Ref normal immunoglobulin, human injection 16% IM Ref BCG vaccine dried injection ID 20 dose vial HC2 diphtheria-pertussis-tetanus (DPT) injection IM/deep SC (20 dose vial) HC2 measles vaccine injection IM/deep SC (10 dose vial) HC2 poliomyelitis vaccine (live attenuated) oral solution 20 dose HC2 tetanus toxoid vaccine (20 dose vial) injection IM/deep SC HC2 hepatitis B vaccine inj IM/deep SC single dose HC2 meningococcal vaccine A+C inj IM/deep SC single dose HC2 plague vaccine inj IM/deep SC single dose HC2 rabies vaccine human diploid inj IM/deep SC single dose HC2 rubella vaccine inj IM/deep SC single dose H typhoid vaccine inj IM/deep SC single dose HC2 yellow fever vaccine inj SC single dose HC2 alcuronium chloride injection 5mg/mL IV Ref atracurium besylate injection 10mg/mL Ref edrophonium injection 10mg/mL IV H neostigmine tablet 15mg HC4 neostigmine injection 500µg/mL IM/SC H Page 26 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 21. OPHTHALMOLOGICAL PREPARATIONS 21.1 Antiinfective agents 21.1.1 Antiinfective + antiinflammatory agents1 1 for use only where qualified ophthalmological staff is available 21.2 Antiinflammatory agents1 1 for use only where qualified ophthalmological staff is available 21.3 Local anaesthetics1 1 for use only where qualified ophthalmological staff is available 21.4 Miotics and antiglaucoma drugs1 1 for use only where qualified ophthalmological staff is available pancuronium bromide injection 2mg/mL IV Ref suxamethonium injection 50mg/mL IV/IVinf HC4 tubocurarine injection 10mg/mL IV H aciclovir eye ointment 3% Ref chloramphenicol eye ointment 1% HC2 chloramphenicol eye drops 0.5% HC2 gentamicin eye/ear drops 0.3% HC4 idoxuridine eye drops 0.1% Ref idoxuridine eye ointment 0.5% Ref tetracycline eye ointment 1% HC1 neomycin + betamethasone eye drops 0.5% + 0.1% HC4 hydrocortisone + eye drops 1.5% + HC4 oxytetracyline + polymyxin B 0.5% + 0.119% betamethasone eye drops 0.1% HC4 hydrocortisone eye drops 0.5% HC4 hydrocortisone eye ointment 1% HC4 tetracaine (amethocaine) eye drops 0.5% H tetracaine (amethocaine) eye drops 1% H Page 27 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 21.5 Mydriatics1 1 For use only where ophthalmological expertise available 21.6 Astringents1 1 For use only where ophthalmological expertise available 22. OXYTOCICS & ANTI-OXYTOCICS 22.1 Oxytocics 22.2 Antioxytocics 23. PERITONEAL & HAEMODIALYSIS SOLUTIONS 2 See product literature for details of presentation 24. PSYCHOTHERAPEUTIC DRUGS acetazolamide tablet 250mg HC4 pilocarpine eye drops 2% HC4 pilocarpine eye drops 4% HC4 timolol eye drops 0.25% Ref timolol eye drops 0.5% Ref atropine eye drops 1% H cyclopentolate eye drops 2% Ref phenylephrine eye drops 10% HC zinc sulphate eye drops 0.25% HC4 ergometrine tablet 200µg HC4 ergometrine + oxytocin injection 500µg + 5 IU/mL IM HC2 methylergometrine inj 200µg/mL IM/slow IV HC2 oxytocin inj 10 IU/mL slow IV/inf H salbutamol tablet 4mg HC3 salbutamol injection 1mg/mL IV inf HC4 electrolyte solutions for dialysis2 Ref amitriptyline tablet 25mg HC4 carbamazepine tablet 200mg HC4 chlordiazepoxide tablet 10mg HC4 Page 28 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 25. DRUGS ACTING ON THE RESPIRATORY TRACT 25.1 Antiasthmatic drugs 25.2 Antitussive drug 25.3 Cough soothing preparation 26. SOLUTIONS CORRECTING WATER, ELECTROLYTE, & ACID-BASE DISTURBANCES chlordiazepoxide tablet 25mg HC4 chlorpromazine tablet 25mg HC2 chlorpromazine tablet 100mg HC2 chlorpromazine injection 25mg/mL deep IM HC2 diazepam inj 5mg/mL IM/slow IV/IVinf HC4 diazepam tablet 5mg HC4 fluphenazine decanoate inj oily 25mg/mL deep IM Ref haloperidol tablet 5mg Ref haloperidol tablet 10mg Ref haloperidol injection 5mg/mL IM Ref haloperidol decanoate inj oily 50mg/mL deep IM Ref haloperidol decanoate inj oily 100mg/mL deep IM Ref imipramine tablet 25mg HC4 lithium carbonate tablet 250mg Ref lorazepam tablet 2mg Ref nitrazepam tablet 5mg HC4 thioridazine tablet 25mg Ref thioridazine tablet 100mg Ref trifluoperazine tablet 5mg H zuclopenthixol decanoate inj oily 200mg/mL deep IM R aminophylline tablet 100 mg HC3 aminophylline inj 25mg/mL slow IV/IVinf HC4 beclomethasone inhaler 50µg/metered dose HC4 epinephrine (adrenaline) injection 1mg/mL SC HC2 salbutamol nebuliser solution 2.5mg/mL H salbutamol nebuliser solution 5mg/mL H salbutamol inhaler 100µg/metered dose HC4 salbutamol tablet 4mg HC3 sodium cromoglycate inhaler 5mg/metered dose for adults) HC4 codeine phosphate tablet 30mg (for adults) HC4 simple linctus syrup (BNF formula) HC2 Page 29 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 26.1 For oral rehydration 26.2 Parenterals 26.3 Miscellaneous 27. VITAMINS & MINERALS 1 Contains: nicotinamide 40mg, pyridoxine HCl 4mg, riboflavine 4mg, thiamine HCl 10mg/2mL amp 28. EAR, NOSE & OROPHARYNGEAL PREPARATIONS 28.1 Ear preparations oral rehydration salts powder for 1 L WHO citrate formula) HC1 calcium gluconate injection 100mg/mL (10%) HC1 Darrow’s solution infusion ½ strength in 2.5% glucose HC2 glucose infusion 5% HC2 glucose infusion 50% HC3 potassium chloride inj 150mg/mL slow IV inf H sodium bicarbonate injection 8.4% slow IV H sodium chloride infusion 0.9% HC2 sodium lactate compound Hartmann’s or Ringer-Lactate solution) infusion HC4 water for injection injection 2mL IV/IM HC2 water for injection injection 5mL IV/IM HC2 water for injection injection 10mL IV/IM HC2 ascorbic acid (vitamin C) tablet 100mg HC3 calcium lactate tablet 300mg HC3 ergocalciferol (vitamin D2) tablet or capsule 250µg 10,000 IU) Ref multivitamin tablet (BPC 73) HC1 nicotinamide tablet 50mg HC4 potassium chloride tablet 600mg SR H pyridoxine (vitamin B6) tablet 50mg HC4 retinol (vitamin A) capsule (drops) 50,000 IU HC2 retinol (vitamin A) capsule (drops) 100,000 IU HC2 retinol (vitamin A) capsule (drops) 200,000 IU HC2 vitamin B complex injection IM1 HC4 vitamin B complex (strong) tablet (BPC 73) HC4 betamethasone ear/eye drops 0.1% H Page 30 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200. 28.2 Nasal preparations 28.3 Oropharygeal preparations 29. DRUGS FOR NEUROSURGICAL USE 29.1 For cerebral metabolism/perfusion National Drug Authority Secretariat Office, Plot 93 Buganda Road PO Box 23096 Kampala Tel: 255665/347391/347392 Fax: 255758 Email: nda@imul.com clotrimazole solution 1% H gentamicin ear drops 0.3% H beclomethasone nasal spray 50µg/metered dose H ephedrine nasal drops 1% (for adults) H lignocaine + adrenaline nasal drops 2% +1:100,000 Ref xylometazoline nasal drops 0.05% HC4 xylometazoline nasal drops 0.1% HC4 lidocaine (lignocaine) lozenges 4% HC4 lidocaine (lignocaine) spray 5% HC4 miconazole oral gel 2% HC4 povidone-iodine mouthwash/gargle 1% HC3 triamcinolone acetonide oral paste 0.1% H piracetam tablet 800mg R piracetam injection 125mg/mL IV/IM R Page 31 of 31img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200.

View the publication

You are currently offline. Some pages or content may fail to load.